American Journal of Transplantation

American Journal of Transplantation
Title	American Journal of Transplantation
Discipline	Transplantation medicine
Language	English
Editor	James F. Markmann
Publisher	Wiley-Blackwell on behalf of the American Society of Transplant Surgeons and the American Society of Transplantation
Country	United States
History	2001–present
Frequency	Monthly

American Journal of Transplantation is a peer-reviewed medical journal focusing on solid organ and hematopoietic transplantation research. It publishes original research, reviews, guidelines, and consensus statements that inform clinicians, surgeons, and researchers across transplantation surgery, immunology, and infectious diseases. The journal serves as a forum connecting clinical trial results, registry analyses, and policy discussions affecting transplant practice and organ allocation.

History

The journal was established in 2001 to consolidate transplantation scholarship previously scattered across specialty outlets; its founding linked stakeholders such as the American Society of Transplant Surgeons, the American Society of Transplantation, and publishers like Wiley-Blackwell and Lippincott Williams & Wilkins. Early editorial leadership included figures associated with institutions such as Massachusetts General Hospital, Johns Hopkins Hospital, Mayo Clinic, and Cleveland Clinic. Over time the journal has chronicled developments connected to landmark events and programs including the United Network for Organ Sharing, the expansion of kidney transplantation networks, advances emanating from laboratories affiliated with Harvard Medical School, Stanford University School of Medicine, University of California, San Francisco, and policy shifts influenced by the Organ Procurement and Transplantation Network. Coverage has reflected outcomes after innovations like the adoption of the Model for End-Stage Liver Disease allocation, reports from the International Liver Transplantation Society, and response to crises such as infectious outbreaks in transplant populations.

Scope and Content

The journal covers clinical transplantation topics including outcomes from kidney transplantation, liver transplantation, heart transplantation, lung transplantation, and pancreas transplantation, as well as cellular therapies like hematopoietic stem cell transplantation. Content spans clinical trials from groups such as the National Institutes of Health, multicenter registry analyses from organizations like the Scientific Registry of Transplant Recipients, translational studies from laboratories at institutions like Columbia University Medical Center and University of Cambridge, and guideline papers issued with societies such as the European Society for Organ Transplantation and the International Society for Heart and Lung Transplantation. Specific thematic areas include immunosuppression strategies pioneered at centers including Baylor College of Medicine and University of Toronto, infectious complications studied at Centers for Disease Control and Prevention, and ethical or legal issues intersecting with agencies such as the Department of Health and Human Services and courts like the United States Supreme Court when transplant policies have been litigated.

Editorial Board and Publication Practices

The editorial board traditionally comprises clinicians and investigators from prominent centers including Yale School of Medicine, University of Pittsburgh Medical Center, Imperial College London, and Karolinska Institutet. Editors coordinate peer review with reviewers affiliated with institutions such as Mount Sinai Health System and Indiana University School of Medicine and adhere to standards promoted by organizations like the Committee on Publication Ethics and the International Committee of Medical Journal Editors. The journal publishes randomized controlled trials, prospective cohort studies, meta-analyses, and consensus guidelines developed with participation from societies including the American College of Surgeons and the Royal College of Physicians. Transparency measures have involved disclosure policies in line with guidance from agencies such as the National Academies of Sciences, Engineering, and Medicine and registries like ClinicalTrials.gov.

Abstracting and Indexing

The journal is indexed in major biomedical databases and citation services including PubMed, MEDLINE, Scopus, and Web of Science. Bibliographic coverage enables tracking by entities such as the National Library of Medicine, citation metrics reported by Clarivate Analytics, and inclusion in institutional repositories at universities such as Oxford University, University of Toronto Libraries, and University of Melbourne. Indexing facilitates discoverability for researchers at centers like Duke University School of Medicine and Flinders University and for policy analysts at organizations including World Health Organization.

Impact and Reception

The journal has been influential in shaping clinical practice and policy, reflected in citation impact as reported by vendors such as Clarivate Analytics and discussed in reviews from outlets like The Lancet and New England Journal of Medicine. Its articles have informed guidelines from the American Society of Transplantation and catalyzed debates at conferences including the American Transplant Congress and meetings organized by the European Society for Organ Transplantation. Reception among transplant communities at institutions such as Mount Sinai Hospital and Royal Prince Alfred Hospital has been largely positive, while methodological critiques have appeared in forums associated with BMJ and PLOS Medicine.

Notable Articles and Special Issues

Noteworthy contributions have reported on long-term outcomes in cohorts published by teams from University of Pennsylvania, innovations in immunomodulation from Fred Hutchinson Cancer Research Center, and registry analyses from the Scientific Registry of Transplant Recipients. Special issues and supplements have addressed topics like xenotransplantation involving research from University of Pittsburgh Medical Center, organ preservation techniques developed at Stanford University, and COVID-19 impacts on transplantation studied by groups at Imperial College London and Mount Sinai Health System. Consensus conferences sponsored with entities such as the Transplantation Society and the International Xenotransplantation Association have appeared as themed collections.

Access and Subscription Model

Published by Wiley-Blackwell on behalf of professional societies including the American Society of Transplantation and the American Society of Transplant Surgeons, the journal follows a hybrid access model offering subscription-based content alongside open access options compliant with funder mandates from organizations such as the Wellcome Trust and the Bill & Melinda Gates Foundation. Institutional subscriptions are common at academic centers like Harvard Medical School and University of California campuses, while individual membership bundles with societies provide reduced rates for members of American Society of Transplantation and American Society of Transplant Surgeons.

Category:Transplantation medical journals